Stocks
Elicio Therapeutics, Inc.ELTX
NASDAQHealthcareBiotechnology$1.90
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing immunotherapies for cancer, with a focus on personalized neoantigen vaccines and targeted therapies. Its lead candidates are in early-phase trials, and investors track the stock for its pipeline progress and partnership potential.
52W Range: $1.44-$16.00
Congressional Interest in Elicio Therapeutics, Inc. (ELTX)
No congressional trades have been disclosed for Elicio Therapeutics, Inc. (ELTX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading ELTX?
No congressional trades found for this stock.